• Journal of Chest Surgery
• /
• 제41권6호
• /
• pp.759-763
• /
• 2008

전폐절제술을 받았던 환자에서 시행하는 심장 수술은 수술 후 합병증과 사망의 위험이 높다. 내원 33년전 폐결핵으로 좌측 전폐절제술을 받았던 71세 남자환자에서 승모판막 치환술 및 삼첨판막륜 성형술을 성공적으로 시행하였기에 증례와 함께 수술 전 후 폐기능 저하의 예방, 수술 중 승모판막의 노출 및 수술 후 발생한 부정맥에 대한 내용을 문헌고찰과 함께 보고하는 바이다.

• Journal of Chest Surgery
• /
• 제34권7호
• /
• pp.569-573
• /
• 2001

저자들은 양측 폐상엽 국균증으로부터 유발된 객혈 1 례를 경험하였다. 환자는 66세 남자로 간헐적으로 재발된 객혈을 가진 환자로 다량의 객혈로 전원되어 X-ray 검사상 양측 상엽에 공동과 진균구를 관찰되었다. 환자는 불량한 전신상태와 호흡기능을 가져 술후 합병증을 최대한 예방하기 위해 정중 흉골절개에 의한 동시 절제보다는 순차적 절제를 계획해 우측병변을 먼저 절제하고 후에 좌측병변을 절제하였다. 조직 검사상 폐결핵성 병변은 없는 폐국균증으로 확진되고 큰 합병증 없이 회복되어 외래 추적치료중이며 객혈이나 진균증의 재발소견은 없었다.

• Journal of Chest Surgery
• /
• 제25권11호
• /
• pp.1286-1291
• /
• 1992

We have experienced 456 cases of spontaneous pneumothorax from January, 1981 to December, 1991 at the department of Thoracic and Cardiovascular Surgery, Chonbuk National University Hospital. Of these, 102 cases were recurrent pneumothorax. These 102 cases were based on the retrospective clinical analysis, and the results were as follows: The ratio of male to female was 6.2: 1 in male predominance and the old aged patients, over 50 years old, occupied 46.8%a of all patients. Primary spontaneous pneumothorax was 43 cases[42.6%] and secondary spontaneous pneumothorax was 59 cases. The underlying pathology in secondary spontaneous pneumothorax was tuberculosis: 31 cases[30.4%], emphysema and chronic obstructive pulmonary disease: 27 cases[26.1%], Most frequent operative and pathologic findings in the primary and the secondary spontaneous pneumothorax was bullae and blebs at apex. The employed managements were only closed thoracostomy in 41 cases, open thoracot-omy in 61 cases. The operative procedures at thoracotomy were bullectomy or bullae ligation in 37 cases, bullae resection with wedge resection in 8 cases, bullae resection with segmentectomy in 6 cases, bullae resection with decortication in 3 cases, lobectomy in 5 cases, decortication in 2 cases. Complications were subcutaneous emphysema[5 cases], wound infection[1 case], and temporary pulmonary insufficiency[1 cases]

• Tuberculosis and Respiratory Diseases
• /
• 제62권3호
• /
• pp.223-226
• /
• 2007

저자들은 도색공장에서 작업 도중 우연히 누출된 tetrafluoroethylene 가스의 흡입으로 인하여 급성폐손상을 받았으나 보존적 치료로 별다른 합병증 없이 비교적 짧은 기간에 치유된 남자 환자 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

• Journal of Chest Surgery
• /
• 제25권6호
• /
• pp.637-644
• /
• 1992

The incidence of thoracic empyema has been reduced with the advent of antimicrobial agents. But, there are remained many significant problems in the management of thoracic empyema because of the empyema associated with bronchopleural fistula, other complications, This is a clinical analysis of 76 cases of thoracic empyema who had been treated from August 1975 to July 1991 in the Chest Surgery Department, Chung-Ang University Hospital. This report dealed with the incidence, etiology and symptoms, duration of hospital stay, therapeutic methods and review of literatures in the aspect of thoracic empyema, The results were as follows: 1. Predominance of male [3 : 1] and right side [1.5 : 1] were recorded. 2. The main symptom was the chest pain [55%], dyspnea[36%], fever[33%], cough [23%] and others. 3, The most common predisposing causatic diseases were pulmonary tuberculosis[33%] and pneumonia[31%], but also uncertain cases were 15%.4. Searching for the causatic organisms, there were not-identified[49%], streptoccocci [17%], staphylococci[12%], mixed infection[12%], AFB bacilli[7%]. 5. The range of hospital stay was from 6 to 146 days and the average duration was 29.4 days, 6. The results were good as the methods of closed thoracostomy[52%], decortication [23%], thoracentesis[15%], rib resection and drainage[4%], open drainage[4%], pleuropneumonectomy [4%]. 7. The serious complications or mortality didn`t developed.

• Tuberculosis and Respiratory Diseases
• /
• 제81권2호
• /
• pp.106-115
• /
• 2018

Chest tube insertion is a common procedure usually done for the purpose of draining accumulated air or fluid in the pleural cavity. Small-bore chest tubes (${\leq}14F$) are generally recommended as the first-line therapy for spontaneous pneumothorax in non-ventilated patients and pleural effusions in general, with the possible exception of hemothoraces and malignant effusions (for which an immediate pleurodesis is planned). Large-bore chest drains may be useful for very large air leaks, as well as post-ineffective trial with small-bore drains. Chest tube insertion should be guided by imaging, either bedside ultrasonography or, less commonly, computed tomography. The so-called trocar technique must be avoided. Instead, blunt dissection (for tubes >24F) or the Seldinger technique should be used. All chest tubes are connected to a drainage system device: flutter valve, underwater seal, electronic systems or, for indwelling pleural catheters (IPC), vacuum bottles. The classic, three-bottle drainage system requires either (external) wall suction or gravity ("water seal") drainage (the former not being routinely recommended unless the latter is not effective). The optimal timing for tube removal is still a matter of controversy; however, the use of digital drainage systems facilitates informed and prudent decision-making in that area. A drain-clamping test before tube withdrawal is generally not advocated. Pain, drain blockage and accidental dislodgment are common complications of small-bore drains; the most dreaded complications include organ injury, hemothorax, infections, and re-expansion pulmonary edema. IPC represent a first-line palliative therapy of malignant pleural effusions in many centers. The optimal frequency of drainage, for IPC, has not been formally agreed upon or otherwise officially established.

• Journal of Chest Surgery
• /
• 제23권3호
• /
• pp.566-571
• /
• 1990

The Bronchial stump disruption in bronchopleural fistula with empyema thoracis after pneumonectomy has remained one of the most dreaded complications of thoracic surgery. Management of chronic bronchopleural fistula still poses a therapeutic dilemma in spite of various surgical techniques that have been attempted to control this complication. Only recently, transsternal transpericardial approach for repair of the postpneumonectomy bronchopleural fistula has been utilized in some cases. The patient was a 31 year-old woman who was admitted to our hospital on August 18th, 1989 due to right postpneumonectomy bronchopleural fistula with empyema thoracis for 5 years since she had undergone right pneumonectomy due to pulmonary tuberculosis at E-hospital in 1984. Transsternal transpericardial closure of the fistula was employed and then the thoracic catheter was removed two months later, after the empyema cavity was sterilized by the Clagett method. So, we think this surgical technique is a relatively simple and effective method to the control of chronic postpneumonectomy bronchopleural fistula with empyema thoracis.

• Tuberculosis and Respiratory Diseases
• /
• 제45권1호
• /
• pp.57-67
• /
• 1998

연구목적: 폐암은 근치적 폐절제술이 가장 효과적인 치료법이지만 폐암 환자들은 흔히 고령이면서 흡연으로 인한 폐기능저하가 동반된 경우가 많고 정상 폐조직을 광범위하게 절제하게 되므로 다른 수술보다 수술 후 사망율 및 폐합병증이 더욱 문제시 되고 있다. 이에 저자들은 폐암환자의 폐절제술 후 사망 및 합병증과 관련된 수술전 인자를 알아보고자 본 연구를 시행하였다. 방 법: 1995년 10월부터 1996년 8월까지 삼성서울병원에서 폐절제술을 시행받는 환자를 대상으로 전향적 연구를 시행하였고 수술후 최종진단이 폐암이 아니거나 폐절제가 시행되지 않았던 환자는 최종대상에서 제외하였다. 수술전에 대상환자의 성별, 연령, 체중감소의 정도, 동반질환, 폐쇄성폐렴여부를 조사하였고, 헤마토크릿, 혈청알부민, 심전도, 안정시동맥혈가스, $FEV_1$, DLco를 비롯한 폐활량검사, 운동부하 폐기능 검사를 시행하였으며 폐관류주사률 이용하여 수술후 폐기능예측지표를 산출하였다. 수술시 집도의, 폐절제범위, 수술시간, 수술후 병기, 수술후 중환자실 체류 시간을 기록하였고 사망 및 합병증은 수술후 30 일내의 사망, 폐렴이나 호흡부전 등과 같은 폐합병증, 48시간 이상의 중환자실 입원, 심장계합병증, 농흉, 출혈, 반회후두신경손상 등 기타 합병증으로 분류하여 수술후 발생여부를 확인하였다. 결 과: 최종 대상환자는 92명이었고 연령은 42~82세로 중앙값은 62세였으며 $FEV_1$은 $2.37{\pm}0.06L$으로 2.0L 이하인 환자는 29명이었다. 수술은 54예가 엽절제술, 12예가 이엽절제술, 26예가 전폐절제술을 시행받았다. 수술후 사망이 3예에서 있었고 폐합병증이 10예, 48시간이상의 중환자실 입원이 16예, 심장 합병증이 9예, 기타 합병증이 11예에서 각각 발생하였으며 사망과 관련된 수술전 인자로는 연령, 혈청알부민, DLco, ppo-DLco, postoperative predicted product(PPP), Wmax, $VO_2$max, ppo-$VO_2$max이었고(p<0.05), ppo-$VO_2$max가 10ml/kg/min이하인 환자 3명은 모두 사망한 반면 10ml/kg/min아상인 환자에서는 사망이 없었다(p<0.01). 수술후 폐합병증은 수술전 체중감소, 체적인자, 흡연량, 호흡곤란의 정도, 혈청알부민, FVC, $FEV_1$, MVV, DLco, ppo-$FEV_1$, ppo-DLco, PPP, Wmax, $VO_2$max, ppo-$VO_2$max, 폐절제술 범위와 밀접한 관련이 있었다 (p<0.05). 그러나 다변량분석에 의해 사망과 관련하여 유의한 지표는 체중감소정도이며 (p<0.05), 폐합병증과 관련하여 유의한 지표는 체중감소정도, 호흡곤란지수, 혈청알부민, ppo-DLco, 폐절제범위정도이었다 (p<0.05). 결 론: 폐암환자의 수술후 사망 및 폐합병증과 관련하여 유용한 예견지표는 체중감소정도, 호흡곤란정도, 폐절제범위 등 폐기능검사와 관련되지 않은 지표들이 중요한 예견지표였으나 운동부하폐기능검사지표들은 수술후 사망 및 합병증을 예측하는데 유용한 정보를 제공할 것으로 생각되며, 특히 ppo-$VO_2$max가 10ml/kg/mm이하인 환자는 수술후 사망율이 높을 것으로 추정된다.

• Tuberculosis and Respiratory Diseases
• /
• 제59권5호
• /
• pp.487-496
• /
• 2005

연구배경 : 우심실부전 또는 쇽을 보였던 중증 폐색전증에서 혈전용해요법 혹은 항응고요법을 시행했을 때 예후의 차이에 대해 조사해 보고자 하였다. 방 법 : 1995년 1월부터 2004년 12월까지 서울아산병원에 입원했던 폐색전증 환자 중에서 우심실부전 혹은 쇽이 있었던 총 60명의 환자를 대상으로 의무기록 분석을 통해서 후향적으로 조사하였다. 결 과 : 총 57명의 환자가 혈전용해요법 또는 항응고요법을 시행 받았으며, 이 중 혈전용해제는 13명(23%)에서, 항응고제는 44명(77%)에서 사용되었다. 혈전용해요법 군과 항응고요법 군에서 APACHEII 점수나 SOFA 점수에 차이는 없었고 사망률은 각각 46% (6/13), 16% (7/44)였다(p=0.054). 쇽이 있는 19명(33%)의 환자 중 혈전용해요법은 9명(47%), 항응고요법은 10명(53%)에서 시행되었고 사망률은 각각 44% (4/9), 30% (3/10)로 차이가 없었다(p=0.650). 38명(67%)의 우심실부전 군에서 혈전용해요법은 4명(11%), 항응고요법은 34명(89%)에서 시행되었고 사망률은 50% (2/4), 24% (8/34)로 차이가 없었다(p=0.279). 중요 출혈부작용은 혈전용해요법 군과 항응고요법 군에서 23% (3/13), 5% (2/44)로 혈전용해요법이 높은 경향을 보였다(p=0.072). 결 론 : 중증 폐혈전색전증 환자에서 쇽 군과 우심실부전군을 각각 혈전용해요법과 항응고요법으로 치료했을 때, 두 군 모두에서 혈전용해요법이 항응고요법에 비해 사망률을 감소시키지 못했으며, 출혈부작용은 높은 경향을 보였다. 그러므로 우리나라에서 전향적 대규모 연구가 필요할 것으로 사료된다.

• Journal of Chest Surgery
• /
• 제33권3호
• /
• pp.231-239
• /
• 2000

Background: This retrospective study tries to identify specific risk factors that may increase complication rates after the surgical treatment of tuberculous destroyed lung. Material and method: A retrospective study was performed on forty-seven patients, who received surgical treatment for tuberculous destroyed lung in the Department of Thoracic and Cardiovascular Surgery at Hanyang University Hospital from 1988 to 1998, to identify specific preoperative risk factors related to postoperative complications. Fisher's exact test was used to identify the correlations between the complications and right pneumonectomy, preoperative FEV1, predicted postoperative FEV1, massive hemoptysis, postoperative persistent empyema. Result: Hospital mortality and morbidity rates of the patients who received surgical treatment for tuberculous destroyed lung were 6.4% and 29.7%, respectively. In view of the hospital mortality and morbidity rates as a whole, predicted postoperative FEV1 less than 0.8L(p<0.005), preoperative FEV1 less than 1.8L(p=0.01), massive hemoptysis(p<0.005), postoperative persistent positive sputum cultures(p<0.0005), and the presence of multi drug resistant tuberculosis(p<0.05) presented statistically significant correlations. Among the postoperative complications, bronchopleural fistula, the most common complication, was found to have statistically significant corrleations with the preoperative empyema(p<0.05) and postoperative persistent positive sputum cultures(p<0.05). Conclusion: Although mortality and morbidity rates after surgical treatment of tuberculous destroyed lung were relatively low, when predicted postoperative FEV1 was less than 0.8L, when preoperative FEV1 was less than 1.8L, when massive hemoptysis was present, when postoperative sputum cultures were persistently positive, and when multi drug resistant tuberculosis was present, the rates were significantly higher.